bortada solution for injection
stada arzneimittel gmbh, germany - bortezomib - solution for injection - 2.5 mg
veltero solution for injection
saudi amarox, saudi arabia - bortezomib - solution for injection - 3.5 mg
bortezomib 3.5 mg powder for solution for injection
msn labs europe limited - bortezomib - powder for solution for injection - bortezomib
bortezomib 3.5 mg powder for solution for injection
baxter holding b.v. - bortezomib - powder for solution for injection - bortezomib
bortezomib fresenius kabi 3.5 mg
neopharm (israel) 1996 ltd - bortezomib - powder for solution for injection - bortezomib 3.5 mg/vial - bortezomib - multiple myelomabortezomib fresenius kabi is indicated for the treatment of adult patients with multiple myeloma.mantle cell lymphomabortezomib fresenius kabi for injection is indicated for the treatment of patients with mantle cell lymphoma who have received at least one prior therapy. bortezomib fresenius kabi in combination with rituximab, cyclophosphamide, doxorubicin and prednisone is indicated for the treatment of adult patients with previously untreated mantle cell lymphoma who are unsuitable for haematopoietic stem cell transplantation.
bortezomib 3.5 mg powder for solution for injection
reddy holding gmbh - bortezomib - powder for solution for injection - bortezomib
bortebin powder and solution for solution for injectio
bortezomib - powder and solution for solution for injectio - 3.5mg/vial - bortezomib
bortezomib for injection 2 mg
bortezomib ih - injection - 2 mg/vial - bortezomib
bortezomib for injection 3.5 mg
bortezomib ih - injection - 3.5 mg/vial - bortezomib
mibzo injection
msn laboratories private limited msn house”, plot no.: c-24, industrial - bortezomib - injection - 3.5 mg/vial - bortezomib